|
|
|
| Featured Events |
|
|
|
|
 |
| Recent Publications |
|
|
|
|
|
|
A free market will help fix health care
11.29.2012
Neurologists are about to feel the sting of the Affordable Care Act. Beginning Jan. 1, Medicare will be paying them less for electrodiagnostic procedures used in identifying and treating a wide range of nerve and muscle disorders.
More
|
|
 |
|
States Looking to Exchange Obamacare’s Insurance Exchanges
11.29.2012
The next act in the Obamacare saga is about to begin—and it’s going to be tragic. Dec. 14 marks the deadline for states to reveal their plans for constructing insurance exchanges in line with the health care law’s dictates.
More
|
|
|
|
Obamacare's Rationers Employ The "It's Good For You" Defense
11.27.2012
Obamacare’s backers have a plan to justify their attempts to ration medicine — by saying that it’s good for you.
More
|
|
|
|
Republican Rx: Parental Choice in Education
11.27.2012
In the aftermath of Mitt Romney’s defeat, Republicans are scrambling to find a winning electoral formula.
More
|
|
|
|
Avoiding The Fiscal Cliff By Fixing The Fiscal Hole
11.21.2012
The President and Congress may throw America into another recession, thanks to the Balanced Budget Act, which was crafted so as to punish the entire country with brutal spending cuts and tax increases if politicians couldn’t agree amongst themselves on a kinder, gentler plan to tame the deficit.
More
|
|
|
|
End Medicare As We Know It Or It Will Come To Its Own End
11.20.2012
As Republican leaders in Congress prepare to talk turkey on the federal budget with their Democratic counterparts in the aftermath of the election, it's time for everyone to face a hard truth — we must end Medicare as we know it.
More
|
|
|
|
Obamacare causing doctor depression
11.15.2012
Thanks to Obamacare, America’s corps of doctors appears to have a case of the blues.
More
|
|
|
|
In The Aftermath Of Obama's Re-Election, What's Next For Health Care?
11.15.2012
With his victory last week, President Obama has effectively cemented his signature healthcare law into place — at least for another four years.
More
|
|
|
|
Even if Prop. 30 had failed, our schools don't have to
11.14.2012
Voters accepted Proposition 30, Gov. Jerry Brown's tax-hike measure, but it's pass time for lawmakers and education officials to think outside their conventional box and look at school models that deliver high performance at a lower cost. Luckily for California, such schools are already up and running and succeeding in the state.
More
|
|
|
|
In Debates Romney Passes Education Test that Obama Fails
11.8.2012
In the presidential debates and in recent interviews, it’s clear that Mitt Romney realizes something that President Obama can’t seem to fathom: the federal government is not the nation’s school board.
More
|
|
|
|
|
|
|
Big Government and Health-Care Stocks: A Happy Marriage?
What with the underwhelming market response to my previous article discussing the effect of the 2010 federal Patient Protection and Affordable Care Act (PPACA) on health insurers, I was pretty astonished (and relieved) to see Citigroup equity strategist Tobias Levkovich state many of the concerns which have occupied me.
Read post
|
|
 |
|
Leavitt: Most States Won't Have Exchanges By Deadline
Former U.S. Secretary of Health & Human Services Mike Leavitt has announced that most states will not have Health Benefits Exchanges up and running by January 2014, when PPACA requires that they be covering patients who will have lost their employer-based benefits.
Read post
|
|
|
|
Path Dependency in Medicare Reform
I first learned about path dependency when studying physics — but it surely applies to public policy, too. Despite the scholarly disputations about health reform, what drives most voters are not questions about the solvency of Medicare or beneficiaries’ access to care, but fear of change.
Read post
|
|
|
|
Grim Reality of Medicare Reform
As one of the first conservatives to criticize Paul Ryan’s Medicare reform, I was pretty excited to read Andrew McCarthy’s spirited attack against the very existence of Medicare. According to McCarthy, it’s a wholesale scam, and he doesn’t mind telling everyone because he’s neither running for office nor responsible for getting anyone else elected.
Read post
|
|
|
|
Politicizing Premiums Does Not Control Health Costs
Last week, an overwhelming majority of Connecticut legislators passed a bill, SB-11, that would give the executive branch the power to decide whether health plans should be allowed to increase their premiums at rates that keep pace with medical costs. Health plans may be a politically attractive target, but giving politicians the power to approve premiums causes other problems – and doesn’t even hold down rate increases.
Read post
|
|
|
|
Will There Be Health Benefits Exchanges By 2014?
Despite advice from most free-market analysis, some Republican governors are executing the Patient Protection and Affordable Care Act (PPACA) by establishing Health Benefits Exchanges. These governors dislike PPACA, but they believe that exchanges can be vehicles for more choice than the federal law anticipates. But I think that the real news is how much difficulty states that want to implement PPACA as fast as possible are having. Read the entire article here.
Read post
|
|
|
|
A Pfizer Break up? Maybe Not Such a Great Idea
In my second Forbes.com The Apothecary blog, I look again at the argument (supported by almost everyone on Wall Street) that Pfizer should be broken up. Certainly, there's a credible contrary view.
Read it here.
Read post
|
|
|
|
Will Kathy Hochul Vote to Repeal Obamacare?
The surprise victory of the Democratic candidate in NY-26’s special election yesterday teaches a curious lesson: Seniors who rose up against Obamacare’s Medicare cuts at town-hall meetings in the summer of 2009 appear to have risen up against Paul Ryan’s Medicare plan in the spring of 2011.
Or maybe they didn't. Read more at National Review Online.
Read post
|
|
|
|
Comparative-Effectiveness Research: How Many Lives Will It Cost?
I write a lot over at John Goodman's Health Policy Blog. For every original post, I also write about half a dozen comments on others' posts. I don't usually share the latter here.
However, I was interested to see Dr. Goodman's take on a new paper published by the Center for Medicines in the Public Interest, an outfit which is often tagged as simply a mouthpiece for Big Pharma. Here's what I wrote:
Read post
|
|
|
|
A Pfizer Break Up? That Would Be Something
I have been afforded the great privilege of writing at Forbes Online. Avik Roy, an equity research analyst at Monness, Crespi, Hardt & Co. in New York City, has invited me to collaborate with him on his blog, The Apothecary, which has been hosted by Forbes for a few months.
Read post
|
|
|
 |
|
|
